Ramacciotti E, Barile Agati L, Calderaro D, Aguiar VCR, et al. Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial. Lancet 2021 Dec 15. pii: S0140-6736(21)02392.
PMID: 34921756